Cargando…

Current topics in the surgical treatments for hepatocellular carcinoma

Treatment strategy for hepatocellular carcinoma (HCC) requires optimal selection of therapies based on various factors related to tumor condition and liver functional reserve. Although several evidence‐based guidelines have been proposed for the treatment of HCC, the criteria and range of indication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ban, Daisuke, Ogura, Toshiro, Akahoshi, Keiichi, Tanabe, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881293/ https://www.ncbi.nlm.nih.gov/pubmed/29863117 http://dx.doi.org/10.1002/ags3.12065

Ejemplares similares

Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells
por: Kato, Tomotaka, et al.
Publicado: (2021)

Comprehensive molecular and immunological characterization of hepatocellular carcinoma
por: Shimada, Shu, et al.
Publicado: (2018)

Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma
por: Yagi, Kohei, et al.
Publicado: (2023)

C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer
por: Ono, Hiroaki, et al.
Publicado: (2021)

Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma
por: Akasu, Masafumi, et al.
Publicado: (2021)

Current Trends in Surgical Management of Hepatocellular Carcinoma
por: Angeli-Pahim, Isabella, et al.
Publicado: (2023)

Pancreatic metastasis from renal cell carcinoma presenting as gastrointestinal hemorrhage: a case report
por: Matsui, Satoshi, et al.
Publicado: (2021)

Surgical Treatment of Hepatocellular Carcinoma
por: Zamora-Valdes, Daniel, et al.
Publicado: (2017)

Surgical Treatment for Hepatocellular Carcinoma
por: Madkhali, Ahmad A., et al.
Publicado: (2015)

Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers
por: Murase, Yoshiki, et al.
Publicado: (2021)

Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma
por: Nakao, Keisuke, et al.
Publicado: (2015)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

Regulation of 4-HNE via SMARCA4 Is Associated with Worse Clinical Outcomes in Hepatocellular Carcinoma
por: Watabe, Shiori, et al.
Publicado: (2023)

Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges
por: Wang, Di, et al.
Publicado: (2023)

Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconstruction using saphenous vein grafting for locally advanced pancreatic cancer: a case report
por: Murase, Yoshiki, et al.
Publicado: (2020)

Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
por: Tümen, Deniz, et al.
Publicado: (2022)

Successful Surgical Control of Peritoneal Dissemination of Hepatocellular Carcinoma
por: Yokoigawa, Norio, et al.
Publicado: (2012)

Hepatocellular Carcinoma: Current Management and Future Development—Improved Outcomes with Surgical Resection
por: Kishi, Yoji, et al.
Publicado: (2011)

Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
por: Ishido, Keinosuke, et al.
Publicado: (2020)

The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
por: Shin, Sung Wook
Publicado: (2009)

Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
por: Villarruel-Melquiades, Fernanda, et al.
Publicado: (2023)

Current status and prospect of treatments for recurrent hepatocellular carcinoma
por: Yang, Yu-Qing, et al.
Publicado: (2023)

Hot topics in hepatocellular carcinoma
por: Ielasi, Luca, et al.
Publicado: (2019)

Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
por: Milana, Flavio, et al.
Publicado: (2023)

Current options and future possibilities for the systemic treatment of hepatocellular carcinoma
por: Raoul, Jean-Luc, et al.
Publicado: (2019)

Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
por: Inchingolo, Riccardo, et al.
Publicado: (2019)

Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review)
por: Xue, Dongdong, et al.
Publicado: (2021)

MGMT is frequently inactivated in pancreatic NET-G2 and is associated with the therapeutic activity of STZ-based regimens
por: Yagi, Kohei, et al.
Publicado: (2023)

Pedunculated hepatocellular carcinoma and surgical treatment.
por: Nishizaki, T., et al.
Publicado: (1993)

Current role of microwave ablation in the treatment of small hepatocellular carcinomas
por: Lucchina, Natalie, et al.
Publicado: (2016)

Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review
por: Daher, Saleh, et al.
Publicado: (2017)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
por: Park, Jongmoo, et al.
Publicado: (2019)

DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma
por: Mizuno, Yuki, et al.
Publicado: (2018)

Immunotherapy for hepatocellular carcinoma: Current and future
por: Johnston, Michael P, et al.
Publicado: (2019)

Current Imaging Diagnosis of Hepatocellular Carcinoma
por: Chartampilas, Evangelos, et al.
Publicado: (2022)

Surgical Treatment of Pancreatic Cancer: Currently Debated Topics on Vascular Resection
por: Pedrazzoli, Sergio
Publicado: (2023)

Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
por: Kong, Fan-Hua, et al.
Publicado: (2021)

The Current Status and Future Prospects for Conversion Therapy in the Treatment of Hepatocellular Carcinoma
por: Bai, Jinfeng, et al.
Publicado: (2023)

Hepatocellular carcinoma: early-stage management challenges
por: Erstad, Derek J, et al.
Publicado: (2017)

Dynamic Enhancement Pattern on CT for Predicting Pancreatic Neuroendocrine Neoplasms with Low PAX6 Expression: A Retrospective Observational Study
por: Kimura, Koichiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qsf5tob1pk6msjbr9f0jtv2tt7